Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan ABPM Pilot Study in Hypertension
NCT00886600Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- May 1991
- Primary completion
- May 1992
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of losartan in hypertension (HTN) (4 arms), sponsored by Merck & Co. Primary endpoints: Mean Change From Baseline in 24-hour Diastolic Ambulatory Blood Pressure Monitoring (ABPM) at Week 4 and Mean Change From Baseline in 24-hour Systolic Ambulatory Blood Pressure Monitoring (ABPM) at Week 4. Started May 1991; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00886600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886600.